• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal and Metabolic Medicine
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality Assessment
      • Environmental, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • People and Culture
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
test-tube-knees
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/From Our Labs

Test tube knees

By
K.E.D. Coan
Nov 17, 2015

Every step, every turn, and every bend: each movement we make translates into a strain on a joint and the millimeter-thin layer of cartilage within. It’s no surprise when this wear and tear leads to injury and joint disease. Normally cartilage isn’t very good at repairing itself, but what if an injection could teach achy joints how to grow cartilage as good as new? 

Scientists working toward this goal must overcome a major obstacle: cartilage will only form in the lab when it can establish the same 3D contacts that would exist in a real joint. To make the situation even more complicated, living cartilage constantly responds to mechanical stress by altering its physical and biochemical characteristics. Now, scientists are closer than ever before to creating a “test tube knee” that effectively models our joint and is helping to accelerate the discovery of new treatments for cartilage damage.  

The project started at the Genomics Institute of the Novartis Research Foundation (GNF) in La Jolla, California. Kristen Johnson, a senior investigator at GNF, had been following evidence that a type of stem cell in the joint can be persuaded to produce new cartilage cells, or chondrocytes, if given the right stimulus.

“The cells are almost there, they have the machinery to repair, but they’re just not getting the last step right,” says Johnson. “Our vision is to direct how cells develop – to literally just inject a therapy into a joint to make mature cartilage.”  

To find such triggers, Johnson wanted to test 2.5 million molecules on the stem cells, but first she had to figure out how to set up the massive experiment. For years, researchers had been growing cartilage in the lab using a 3D pellet culture where the cells could grow in any direction, but these conditions were challenging to mimic in the two-dimensional, plate-based format needed for an automated screen of millions of molecules. As described in Johnson’s 2012 Science publication, the trick was to position the cells just right in the plate, providing them with the contacts required to grow. The resulting screen led to the discovery of cartilage-inducing molecules like kartogenin.  

The next step was to explore the inner workings of the newly-formed cartilage, but Johnson’s models were limited in how well they represented a real-life scenario. This cartilage wasn’t truly 3D and it never experienced any of the mechanical stresses that would influence its development and potential to repair. The team needed a healthier, more authentic model, and they also needed to test whether the lab-grown tissue would actually behave like real cartilage mechanically.  

matteo-centola
Matteo Centola builds models that mimic the structure and properties of cartilage in knee joints. Photo by Marta Sanchez-Oro

Matteo Centola, an engineer in the Musculoskeletal Diseases group at the Novartis Institutes for BioMedical Research in Basel, Switzerland, provided the solution with a spongy, biodegradable support structure that can be seeded with stem cells. The tissue is then grown in a bioreactor, which in combination with the porous support material, allows the nutrients and potential treatments to easily flow throughout the developing cartilage, keeping it healthy and uniform.  

“These models are truly 3D and much closer to what would exist in a real joint,” says Johnson.  

While scientists at GNF are studying the molecular pathways that underlie the cartilage formation, Centola’s models can be used to measure the elasticity and toughness of the tissue. His models will also help the team uncover pathways that only become activated when the cartilage experiences mechanical stress.  

“Our ultimate goal is to mimic walking and running in culture,” says Centola. “We want to see how this lab-grown tissue responds to real-world stress.”

Career opportunities

Find career opportunities in Oncology and Immuno-oncology research at Novartis.

Visit our career search page to learn more.


Main image: Scientists track the amount of healthy cartilage in a joint to measure repair before and after a treatment. Image: Kristen Johnson/GNF

Shareline

Scientists perform mechanical checkups on lab-grown cartilage to explore treatments for joint disease
Tweet Tweetpopo
Tags: 
Biomedical Research, Drug Discovery, Novartis Institutes for BioMedical Research, Reimagine Medicine, Musculoskeletal Diseases

K.E.D. Coan

K.E.D. Coan

manages scientific and medical communications in Switzerland and made her debut as a science blogger in 2014. Although her days in the lab have ended for the moment, she finds writing a great way to keep close to the latest research.

    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

Coronavirus
From Our Labs

A visual tour of scientific strategies for combating coronavirus

Wendi Yajnik, Global Head of Academic Partnerships and External Innovation for research
From Our Labs

Advancing medicine through collaboration

Special instrument controlled by a production associate
From Our Labs

Turning the power of nuclear technology into a medical force

You are here

  1. Home ›
  2. Stories ›
  3. From Our Labs

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.